VERU INC. Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31)
VERU INC. (VERU) reported Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31) of $19.39 million for the 6-month period ending 2013-03-31, per its 10-Q filed 2013-05-02.
Discontinued › Income Statement › Other Income
us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries · last filed 2013-05-02
- VERU INC. disclosure on geographic areas, revenue from external customers attributed to foreign countries (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $9.48M, a 21.00% increase year-over-year.
- VERU INC. disclosure on geographic areas, revenue from external customers attributed to foreign countries (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $9.91M, a 14.78% increase year-over-year.
- VERU INC. disclosure on geographic areas, revenue from external customers attributed to foreign countries (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $8.66M.
- VERU INC. disclosure on geographic areas, revenue from external customers attributed to foreign countries (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $7.83M.
| Period end | Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31) 3 month | Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31) 6 month | Disclosure on Geographic Areas, Revenue from External Customers Attributed to Foreign Countries (Deprecated 2013-01-31) 9 month |
|---|---|---|---|
| 2013-03-31 | $9.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $19.39M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $9.91M 10-Q · filed 2013-01-30 | ||
| 2012-06-30 | $8.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-31 | $16.49M derived: sum of 2 quarters · filed 2013-05-02 | $25.12M 10-Q · filed 2012-07-31 |
| 2012-03-31 | $7.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $16.47M 10-Q · filed 2013-05-02 | |
| 2011-12-31 | $8.63M 10-Q · filed 2013-01-30 | ||
| 2011-06-30 | $11.46M 10-Q · filed 2012-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |